PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35105678-0	2022	A Comment on "Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites".	remdesivir	14-24	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	59-104	
35105679-0	2022	Response to Comments on "Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites".	remdesivir	25-35	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	70-115	
34503974-0	2021	Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.	remdesivir	0-10	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	45-90	
34503974-4	2021	In vitro transport experiments demonstrated that remdesivir was the most potent inhibitor of ENT-mediated (3H) uridine uptake (ENT1 IC50: 38.65 mM; ENT2 IC50: 76.72 mM), followed by EIDD-1931 (ENT1 IC50: 258.9 mM; ENT2 IC50: 467.3 mM), while molnupiravir was a modest inhibitor (ENT1 IC50: 701.0 mM; ENT2 IC50: 851.4 mM).	remdesivir	49-59	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	127-131	
34503974-10	2021	Significance Statement Significance statement: This study identified remdesivir and EIDD-1931 as substrates of equilibrative nucleoside transporters 1 and 2.	remdesivir	69-79	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	111-156	
35505633-5	2022	A recent study identified that remdesivir and the active metabolite of molnupiravir, EIDD-1931, are substrates of equilibrative nucleoside transporters 1 and 2 (ENT1 and 2).	remdesivir	31-41	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	161-171